Nature Communications (Oct 2019)

Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome

  • Helen R. Davies,
  • Kirsty Hodgson,
  • Edward Schwalbe,
  • Jonathan Coxhead,
  • Naomi Sinclair,
  • Xueqing Zou,
  • Simon Cockell,
  • Akhtar Husain,
  • Serena Nik-Zainal,
  • Neil Rajan

DOI
https://doi.org/10.1038/s41467-019-12746-w
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 9

Abstract

Read online

CYLD cutaneous syndrome (also known as Brooke-Spiegler syndrome) is characterised by germline mutations in the tumor suppressor CYLD. Here, the authors highlight recurrent mutations in DNMT3A and BCOR, indicating a role for epigenetic dysregulation in this rare genetic skin disease.